← Back to Search

Diagnostic Test

Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Testing for Breast Cancer

N/A
Waitlist Available
Led By Joyce A O'Shaughnessy, MD
Research Sponsored by Biotheranostics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

The purpose of the Breast Cancer Index (BCI) Registry study is to conduct a large scale, population-based prospective registry to evaluate long-term clinical outcome, clinical impact, medication adherence and quality of life in hormone receptor positive (HR+) early-stage breast cancer patients receiving BCI testing as part of routine clinical care to inform extended endocrine therapy.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To determine medication adherence in patients undergoing extended endocrine therapy.
Secondary study objectives
To prospectively assess the impact of BCI on extended endocrine therapy decision-making.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit TestingExperimental Treatment1 Intervention
Female patients diagnosed with hormone receptor-positive (HR+), lymph node-negative (LN-) or lymph node-positive (LN+, with 1-3 positive nodes) early-stage invasive breast cancer, who are distant recurrence-free.

Find a Location

Who is running the clinical trial?

Biotheranostics, Inc.Lead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
Catherine A Schnabel, PhDStudy DirectorBiotheranostics, Inc.
Joyce A O'Shaughnessy, MDPrincipal InvestigatorUS Oncology Network
5 Previous Clinical Trials
252 Total Patients Enrolled
2 Trials studying Breast Cancer
68 Patients Enrolled for Breast Cancer
~1648 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top